{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:55Z","timestamp":1790716615224,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pnpbp.2026.111843","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:07:45Z","timestamp":1784588865000},"page":"111843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histone demethylase PHF2 drives olanzapine-induced dyslipidemia via epigenomic rewiring of hepatic lipogenic genes"],"prefix":"10.1016","volume":"149","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MeiYing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pnpbp.2026.111843_bb0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111843_bb0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1242\/dev.119.4.1301","article-title":"The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3\/forkhead proteins","volume":"119","author":"Ang","year":"1993","journal-title":"Development"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111843_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111843_bb0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncb2228","article-title":"PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B","volume":"13","author":"Baba","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41467-018-04361-y","article-title":"The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity","volume":"9","author":"Bricambert","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41398-021-01762-4","article-title":"Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment","volume":"11","author":"Brocos-Mosquera","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111843_bb0035","article-title":"Quetiapine modulates histone methylation status in oligodendroglia and rescues adolescent behavioral alterations of socially isolated mice","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Psych."},{"issue":"36","key":"10.1016\/j.pnpbp.2026.111843_bb0040","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","article-title":"Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation","volume":"105","author":"Dong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0045","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"F.D.","year":"2005"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111843_bb0050","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.euroneuro.2015.03.002","article-title":"Olanzapine depot exposure in male rats: dose-dependent lipogenic effects without concomitant weight gain","volume":"25","author":"Ferno","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111843_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111843_bb0060","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/diacare.27.8.2086","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement","volume":"27","author":"Holt","year":"2004","journal-title":"Diabetes Care"},{"issue":"42","key":"10.1016\/j.pnpbp.2026.111843_bb0065","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1523\/JNEUROSCI.3272-07.2007","article-title":"Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters","volume":"27","author":"Huang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.587189","article-title":"ChREBP-mediated regulation of lipid metabolism: involvement of the gut microbiota, liver, and adipose tissue","volume":"11","author":"Iizuka","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111843_bb0075","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1242\/dev.133900","article-title":"Cell fate control by pioneer transcription factors","volume":"143","author":"Iwafuchi-Doi","year":"2016","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0080","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/s41467-023-42170-0","article-title":"Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma","volume":"14","author":"Jeong","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111843_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1043-2760(00)00271-X","article-title":"The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism","volume":"11","author":"Kaestner","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2019.02.014","article-title":"Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent","volume":"150","author":"Kao","year":"2019","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111843_bb0095","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2337\/db13-1015","article-title":"MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes","volume":"63","author":"Kurtz","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111843_bb0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tig.2015.10.007","article-title":"Lateral thinking: how histone hodifications regulate gene expression","volume":"32","author":"Lawrence","year":"2016","journal-title":"Trends Genet."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111843_bb0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.14348\/molcells.2014.0180","article-title":"The histone demethylase PHF2 promotes fat cell differentiation as an epigenetic activator of both C\/EBPalpha and C\/EBPdelta","volume":"37","author":"Lee","year":"2014","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0120","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/s41598-020-73983-4","article-title":"Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111843_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104160","article-title":"Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment","volume":"9","author":"Lian","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pnpbp.2026.111843_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.06.010","article-title":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways","volume":"48","author":"Lian","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2026.111843_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2017.12.017","article-title":"NADPH oxidase 4 and endothelial nitric oxide synthase contribute to endothelial dysfunction mediated by histone methylations in metabolic memory","volume":"115","author":"Liao","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111843_bb0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41401-023-01180-w","article-title":"Activation of the PERK-CHOP signaling pathway during endoplasmic reticulum stress contributes to olanzapine-induced dyslipidemia","volume":"45","author":"Liu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0145","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1038\/s41598-017-02884-w","article-title":"Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110692","article-title":"Olanzapine-induced decreases of FGF21 in brown adipose tissue via histone modulations drive UCP1-dependent thermogenetic impairment","volume":"122","author":"Liu","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111843_bb0155","article-title":"FOXA2-interacting FOXP2 prevents epithelial-mesenchymal transition of breast Cancer cells by stimulating E-cadherin and PHF2 transcription","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111843_bb0160","doi-asserted-by":"crossref","DOI":"10.1063\/5.0216272","article-title":"A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn","volume":"161","author":"Lu","year":"2024","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111843_bb0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0170","article-title":"Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects","volume":"16","author":"Moniem","year":"2025","journal-title":"Front. Psych."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030014","article-title":"Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver","volume":"7","author":"Moya","year":"2012","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111843_bb0180","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2337\/db12-0628","article-title":"Epigenetic regulation of adipogenesis by PHF2 histone demethylase","volume":"62","author":"Okuno","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pnpbp.2026.111843_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.pharmtox.48.113006.094731","article-title":"Epigenetics and complex disease: from etiology to new therapeutics","volume":"48","author":"Ptak","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0190","article-title":"Histone deacetylase inhibitors mitigate antipsychotic risperidone-induced motor side effects in aged mice and in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Rodriguez","year":"2022","journal-title":"Front. Psych."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111843_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40261-021-01000-1","article-title":"Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and Meta-analysis of metabolic and cardiovascular side effects","volume":"41","author":"Rognoni","year":"2021","journal-title":"Clin. Drug Investig."},{"issue":"24","key":"10.1016\/j.pnpbp.2026.111843_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249362","article-title":"Understanding mechanisms underlying non-alcoholic fatty liver disease (NAFLD) in mental illness: risperidone and olanzapine Alter the hepatic proteomic signature in mice","volume":"21","author":"Rostama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.pnpbp.2026.111843_bb0205","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111843_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.2008.01334.x","article-title":"Which comes first: atypical antipsychotic treatment or cardiometabolic risk?","volume":"119","author":"Stahl","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104703","article-title":"Epigenetic histone modulations of PPARgamma and related pathways contribute to olanzapine-induced metabolic disorders","volume":"155","author":"Su","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111843_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119143","article-title":"Epigenetic histone methylation of PPARgamma and CPT1A signaling contributes to betahistine preventing olanzapine-induced dyslipidemia","volume":"24","author":"Su","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2025.111425","article-title":"Dataset of histone H3K4me2 modified genes in the liver of female Sprague-Dawley rats with chronic antipsychotic drugs of olanzapine or clozapine","volume":"59","author":"Su","year":"2025","journal-title":"Data Brief"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111843_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111843_bb0235","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41419-021-03676-x","article-title":"Cellular fate of intersex differentiation","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111843_bb0240","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101506RRR","article-title":"FOXA1\/2 depletion drives global reprogramming of differentiation state and metabolism in a human liver cell line and inhibits differentiation of human stem cell-derived hepatic progenitor cells","volume":"37","author":"Warren","year":"2023","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111843_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184282","article-title":"Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways","volume":"12","author":"Weiss","year":"2017","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111843_bb0250","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euroneuro.2011.09.003","article-title":"Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels","volume":"22","author":"Weston-Green","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0255","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/NDT.S208061","article-title":"Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review","volume":"15","author":"Xu","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2026.111843_bb0260","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16466","article-title":"Foxa2 attenuates steatosis and inhibits the NF-kappaB\/IKK signaling pathway in nonalcoholic fatty liver disease","volume":"11","author":"Yang","year":"2023","journal-title":"PeerJ"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:39:22Z","timestamp":1790714362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0278584626002411"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111843","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone demethylase PHF2 drives olanzapine-induced dyslipidemia via epigenomic rewiring of hepatic lipogenic genes","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111843"}}